ClinicalTrials.govpublic full text
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
multiple sclerosis, relapsing-remitting, ocrelizumab, lymph node, lymphocyte, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 912578
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.